“2017, too, was a very good year for Catena and the consolidation of the leading position on the pharmaceutical retail market is one of the main achievements of this year. We will definitely invest in the development of the brand, in remodeling the locations and in retooling in 2018, as well,” the company officials told ZF.
Catena expects growth of 10% in revenue in 2018, following investments in the previous years and the overall development of the pharmaceutical market.
Catena invested EUR15 million in expanding the number of pharmacies and in going digital in 2017.
The pharmaceutical retailer posted growth of 40% in revenue in 2016 compared with 2015, following the introduction of the new Hepatitis C treatment, which drove the overall drug market up.
Catena is the leading pharmaceutical retailer in Romania, followed by Sensiblu, RON1.6 billion revenue in 2016 and 470 pharmacies and Dona, RON902 million revenue last year and 284 pharmacies, Help Net and Ropharma. (EUR1=RON4.6276)
(English version by Loredana Fratila-Cristescu)